BridgeMD
New treatment option for Postoperative Pain
Official title Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07440940
What this study is testing
- What it's testing
- This prospective randomized controlled trial aims to evaluate whether the timing of ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) affects postoperative pain in patients undergoing laparoscopic cholecystectomy. Participants will be randomly assigned to receive the combined regional blocks either before surgical incision or after completion of surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Elective laparoscopic cholecystectomy
- Adults aged 18 to 80 years
- Ability to understand the study procedures and provide informed consent
- American Society of Anesthesiologists (ASA) physical status I-III
You likely can't join if
- Presence of significant pain unrelated to the target disease that may interfere with pain assessment
- Known allergy or contraindication to study medications (ropivacaine, acetaminophen, nefopam, or pethidine)
- Planned single-port laparoscopic cholecystectomy
- American Society of Anesthesiologists (ASA) physical status IV or higher
- Infection of the abdominal wall or skin at the injection site, or anatomical abnormalities of the abdominal wall
- Major neurological, psychiatric, or systemic diseases that may affect pain perception, treatment response, or study evaluation
See the full eligibility criteria
- Elective laparoscopic cholecystectomy
- Adults aged 18 to 80 years
- Ability to understand the study procedures and provide informed consent
- American Society of Anesthesiologists (ASA) physical status I-III
- Presence of significant pain unrelated to the target disease that may interfere with pain assessment
- Known allergy or contraindication to study medications (ropivacaine, acetaminophen, nefopam, or pethidine)
- Planned single-port laparoscopic cholecystectomy
- American Society of Anesthesiologists (ASA) physical status IV or higher
- Infection of the abdominal wall or skin at the injection site, or anatomical abnormalities of the abdominal wall
- Major neurological, psychiatric, or systemic diseases that may affect pain perception, treatment response, or study evaluation
- Requirement for postoperative mechanical ventilation
- Pregnancy or breastfeeding
- Considered unsuitable for the study by the investigator
- Refusal to participate or inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.